Japan’s cost-effectiveness assessment (CEA) panel has approved a revised handling policy for the CEA system for FY2026, with the health…
HOME > ARCHIVE
ARCHIVE
- JCR Pharmaceutical: Sales Down 9.0%, Profits Down 45.1%
December 24, 2001
- Arkray Adds Gastric Cancer as Test Item to Home Health Check
December 24, 2001
- Both Income, Expenses Decreased at Clinics
December 24, 2001
- Re-pricing Rule to Be Introduced for Medical Materials
December 24, 2001
- Medical Facilities Obtain Great Profits with Small Capital: Kenporen Study
December 24, 2001
- Iatron Develops New Reagent to Determine Blood Elastase-1
December 24, 2001
- Sephora to Withdraw from Japan
December 17, 2001
- Quality Reevaluation Completed for Drugs Accounting for 60% of Total Market
December 17, 2001
- Matsumotokiyoshi: Sales, Net Profits Increase 11%, 46.1%, Respectively
December 17, 2001
- REGULATORY NEWS IN BRIEF
December 17, 2001
- Kraft: Dispensing Business Boosts Sales by 16.8%
December 17, 2001
- FTC Issues Recommendation to 9 Wholesalers in the Tohoku Region
December 17, 2001
- BioZak Japan Established to Supply Mfg. Technology on Hepatitis C Agents
December 17, 2001
- Fukuda Denshi to Manufacture ECG in China
December 17, 2001
- Eli Lilly, Chugai to Dissolve Their JV
December 17, 2001
- Hitachi Medical Develops Lung Cancer Diagnosis Support System
December 17, 2001
- EPS: CRO, SMO Businesses Boost Sales by 42.2%
December 17, 2001
- ISI Provides Medical, Pharmaceutical Literature Search Services
December 17, 2001
- AstraZeneca to Launch New Corticosteroid Inhaler, Pulmicort Turbuhaler
December 17, 2001
- JAPANESE LANGUAGE BOOKS
December 17, 2001
ページ
The launch of Elevidys has opened the door to gene therapy for DMD, but research into new treatments is already…
I recently sat down with one of the leading medical directors in Japan to discuss the critical evolution of the medical science liaison (MSL) role.The MSL has transformed from a scientific resource into a strategic partner essential for successful product…
Japan’s Central Social Insurance Medical Council (Chuikyo) on November 5 approved the reimbursement listing for a slate of new medicines,…
The Japanese government on March 7 announced new NHI prices to be applied in the FY2025 drug price revision, revealing…
The Japanese government approved a bill to amend the Pharmaceuticals and Medical Devices (PMD) Act at its Cabinet meeting on…
Japan’s health ministry doled out regulatory approvals for a throng of new medicines on December 27 including Eli Lilly’s obesity…
Japan’s all-important reimbursement policy panel on December 20 approved an outline of drug pricing reforms for FY2024, which enshrines a…